肝细胞癌中调控性RNA的生物学与临床应用
本文综述非编码RNA(ncRNA)在肝细胞癌(HCC)中的生物学功能与临床转化前景。ncRNA通过影响癌细胞内在信号及肿瘤微环境串扰介导HCC发生发展,并有望作为临床生物标志物,但需更多证据支持其临床转化。
要点
- ncRNA通过调控癌细胞信号及微环境串扰参与HCC发生发展。
- ncRNA有望作为HCC临床生物标志物。
- ncRNA临床转化仍需进一步证据支持。
核心结论
- ncRNA在HCC发生发展中起调控作用,并具有临床生物标志物潜力,但临床转化尚需更多证据。
研究设计与样本
- 综述,总结非编码RNA在肝细胞癌中的生物学功能与临床应用前景。
主要发现
- ncRNA通过影响癌细胞内在信号及恶性细胞与微环境间的串扰介导HCC发展。
- ncRNA在疾病状态下表达失调,包括肝细胞癌。
- ncRNA数量随物种复杂性递增,提示其在调控网络维持中的重要作用。
临床怎么用
- ncRNA作为HCC临床生物标志物尚处于研究阶段,暂不宜常规用于临床决策。
局限性
- ncRNA临床转化仍需进一步证据支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Most of the human genome consists of DNA genes that are translated into RNAs but not into proteins. These RNA molecules are named noncoding RNAs (ncRNA). While in the past it was thought that ncRNAs would be redundant without relevant functions, it is now well established that ncRNAs identify a class of regulatory molecules that finely tune cell homeostasis and are deregulated in disease states, including hepatocellular carcinoma (HCC). Of note, the number of ncRNAs within a cell increases progressively, with the complexity of the species indicating their essential role in the maintenance of regulatory networks that affect the intricacy of the organism. ncRNAs have been demonstrated to mediate HCC development and progression by affecting intrinsic cancer cell signaling and crosstalk between malignant cells and the microenvironment. Moreover, ncRNAs hold promise as clinical biomarkers, but further evidence is warranted before their translation and integration within clinical practice.
引用
- Pea A, Jamieson NB, Braconi C, et al. Biology and Clinical Application of Regulatory RNAs in Hepatocellular Carcinoma. Hepatology. 2020. PMID: 32160335. doi:10.1002/hep.31225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。